Recently, a novel mode of inheritance has been described in the yeast Saccharomyces cervisiae. The mechanism is based on the prion hypothesis, which posits that self-perpetuating changes in the conformation of single protein, PrP, underlie the severe neurodegeneration associated with the transmissible spongiform enchephalopathies in mammals. In yeast, two prions, [URE3] and [PSI ϩ ], have been identified, but these factors confer unique phenotypes rather than disease to the organism. In each case, the prion-associated phenotype has been linked to alternative conformations of the Ure2 and Sup35 proteins. Remarkably, Ure2 and Sup35 proteins existing in the alternative conformations have the unique capacity to transmit this physical state to the newly synthesized protein in vivo. Thus, a mechanism exists to ensure replication of the conformational information that underlies protein-only inheritance. We have characterized the mechanism by which Sup35 conformational information is replicated in vitro. 
Background
In 1965, Brian Cox described a modifier of translation termination efficiency, [PSI ϩ ], in the yeast Saccharomyces cerevisiae [1] . The phenotype produced by the [PSI ϩ ] element was first detected in strains carrying a nonsense mutation in an auxotrophic marker and a nonsense suppressor tRNA that was too weak to restore growth. The presence of [PSI ϩ ] caused an increase in the efficiency of the same weak tRNA suppressor, resulting in a detectable level of nonsense suppression (stop codon read-through), and the restoration of growth on selective media.
Early analysis of these strains indicated that the [PSI ϩ ] phenotype (nonsense suppression) is inherited in a non-conventional manner. [PSI ϩ ] strains convert spontaneously into the [psi Ϫ ] state at a low frequency, a process referred to as [PSI ϩ ] curing [1] . The frequency of these events can be increased by growth in the presence of agents that are not mutagenic to nucleic acids, such as methanol or guanidine hydrochloride (GuHCl) [2] . Remarkably, [psi Ϫ ] strains also have the capacity to acquire [PSI ϩ ] de novo at a similarly low, but detectable, frequency [3] . This metastability is difficult to reconcile with a nucleic acid determinant.
Genetic analysis indicated that the [PSI ϩ ] phenotype is a dominant trait that can be transmitted to either mitotic or meiotic progeny through the cytoplasm [1] . In addition, [PSI ϩ ] can be transmitted to other yeast strains if their cytoplasms are allowed to mix in the absence of nuclear fusion [4, 5] . Despite these observations, subsequent experiments failed to link the [PSI ϩ ] phenotype to any of the known cytoplasmic nucleic acids [6, 7] .
Sup35 and the prion hypothesis for [PSI ϩ ]
The first insights into the nature of the [PSI ϩ ] determinant were provided by a series of experiments that established a relationship between [PSI ϩ ] and a nuclear gene known as SUP35. SUP35 had previously been implicated in translation termination [8, 9] and has subsequently been shown to be the eukaryotic release factor 3 (eRF3), a component of the translation-termination complex [10, 11] . Extra copies of the SUP35 gene induced a nonsense suppressor phenotype in yeast strains [12] , and this phenotype persisted even after the SUP35 copy number had returned to wild-type levels [13] . Notably, this suppression phenotype was dependent upon expression of the Sup35 protein [14] and, like [PSI ϩ ], could be cured by GuHCl [13] .
In 1994, Reed Wickner [15] proposed a model for the link between SUP35 and [PSI ϩ ]. This idea, the yeast prion hypothesis, suggests that the [PSI ϩ ] determinant is a self-perpetuating alternative physical state of the Sup35 protein, that is, a protein state that can act as a genetic element. This concept is based upon the mammalian prion hypothesis that had previously been proposed to explain the etiology of the transmissible spongiform encephalopathies (TSEs) [16, 17] . These neurodegenerative disorders are unique in that they can be transmitted as both genetic and infectious diseases [18] . The infectious agent is widely believed to be a protein with an altered self-perpetuating conformation.
Several criteria accompany the hypothesis that proteins can act as genetic elements in yeast [15] . First, the determinant, a prion protein, must have the capacity to exist in at least two stable but physically distinct states. Secondly, these unique states must be linked to distinct phenotypes. Thirdly, a mechanism must exist for replicating the prion state. Molecular-genetic and cell-biological experiments have provided support for each of these points in the case of Sup35.
In [PSI ϩ ] strains, Sup35 protein is present in the cytoplasm in large complexes that have an increased resistance to proteolysis; in [psi Ϫ ] strains, Sup35 protein is soluble and sensitive to proteolysis [19, 20] . These observations formed the basis of the first molecular model for the [PSI ϩ ] phenotype [19, 20] The next major breakthrough in our understanding of [PSI ϩ ] was the realization that assembly of Sup35 and certain fragments in vitro can provide a model for the replication of the prion state of Sup35 [24, 25] . Purified full-length Sup35 protein, or a fragment containing the N-terminal 254 amino acids (NM region) will assemble into fibres after a lag phase in which the protein remains soluble [24] . These fibres share many characteristics with the protein amyloids associated with the TSEs, and other human diseases, including the capacity to bind to the amyloid diagnostic dye Congo Red and induce a shift in its absorbance spectrum (Figure 2A ). In addition, Sup35 fibres are rich in ␤-sheet structure ( Figure 2B) , as is the case for other amyloids [26] .
The key feature of fibre formation that links it to [PSI ϩ ] biology is the ability of small quantities of preformed fibres to accelerate greatly the polymerization of soluble protein ( Figure 2B ). The conformational information present in Sup35 fibres is replicated in vitro using soluble Sup35 as a substrate.
Several observations link the process of amyloid formation in vitro to the propagation of [PSI ϩ ]. First, lysates from [PSI ϩ ] strains, but not [psi Ϫ ] strains, accelerate the conformational conversion and assembly of soluble NM region in vitro [24] . Secondly, the region of the protein that is crucial for fibre formation is also necessary for the inheritance of [PSI ϩ ]. The Sup35 sequence has been divided into three regions, N (amino acids 1-125), M (amino acids 126-254), and C (amino acids 255-685), based on composition and similarity to other proteins [27] [28] [29] . Only fragments of Sup35 containing the N-terminal 125 amino acids (N) will form amyloid in vitro [24, 25] , and this region is both necessary and sufficient for the propagation of [PSI ϩ ] in vivo [30] . Thirdly, like full-length Sup35, a fragment containing the N and M regions can exist in different states (soluble or insoluble) in [psi Ϫ ] and [PSI ϩ ] strains (Figure 1 ) [19, 20] . In vitro, NM forms amyloid fibres, but can also exist in a soluble form for days [24] . Finally, mutations that alter the [PSI] status alter fibre formation in a complementary fashion [14, 24, [31] [32] [33] . To provide just one example, the N region contains five imperfect repeats of the nonapeptide Gln-Gly-Gly-TyrGln (Gln) Gln-Tyr-Asn-Pro [27] [28] [29] . Deletion mutants that have fewer copies of these repeats (⌬BstEII and ⌬R2-5; see Figure 3 ) are unable to support [PSI ϩ ] inheritance in vivo and form amyloid fibres at a reduced rate in vitro [24, 31] . A mutant that has extra copies of the second nonapeptide repeat (R2E2; see Figure 3 ) has an increased rate of spontaneous appearance of [PSI ϩ ] in vivo, and forms amyloid fibres at an accelerated rate in vitro [31] . Taken together, these observations indicate that the formation of amyloid fibres by Sup35 accurately recapitulates the propagation of [PSI ϩ ] in vivo.
Nucleated conformational conversion
We have utilized the process of amyloid fibre formation in vitro to study the mechanism by which proteins replicate their conformational information. Three models have previously been proposed to explain this process [16, 17, 34, 35] . The first model predicts that conformational information is transmitted between monomeric isoforms [17] . The other two models predict that larger protein complexes are the active species; however, one model suggests that complexes catalyse polymerization of only one type of conformer [35] , and the other model predicts that complexes promote conformation conversion during assembly [34] . Using a series of biochemical and microscopic criteria, we have analysed the process of amyloid formation by the NM fragment of Sup35 in vitro and propose a model for replication of this conformation information: nucleated conformation conversion (see Figure 4) [36] . In solutions of pre-formed NM fibres, the species that promotes (e.g. nucleates) the assembly and conformational change of soluble protein is sedimentable at 100 000 g, suggesting that solid-state NM contains the active conformational information. The efficiency of this nucleation is enhanced if fibres are fractured by sonication, suggesting that conformational information is transmitted through fibre ends.
Several lines of evidence indicate that conformational conversion is catalysed during assembly when soluble protein interacts with structured fibre ends. limited proteolysis, 8-anilino-1-naphthalene sulphonic acid binding, and circular dichroism in reactions proceeding at vastly different rates (minutes, hours, days). (ii) The rate of assembly reaches a limit at higher monomer concentrations.
We believe that this limit is imposed by the time required for protein interacting with the ends of fibres to conformationally convert to regenerate a surface that is competent for assembly. If fibres acted as nuclei for polymerization alone, assembly should be linearly dependent on soluble protein concentration. (iii) Assembly time also reaches a limit if different methods that accelerate the process (e.g. fracturing the seed or increasing the collision frequency by agitation) are combined. Again, if fibres catalysed polymerization only, these treatments would be expected to result in an additive effect. Formation of nuclei de novo and assembly onto pre-formed fibres is likely to proceed via an unstructured oligomeric intermediate. Smaller complexes of Sup35 may mediate the nonsense suppressor phenotype, and would be expected to be transmitted cytoplasmically to progeny during cell division more efficiently than larger complexes. If [PSI ϩ ] improves the fitness of strains [37, 38] , it may have evolved to maximize transmission, as distinct from the formation of amyloid fibres by disease-associated proteins in mammals. The in vitro system described here provides a method of assessing the mechanisms by which both intragenic and extragenic modifiers of [PSI ϩ ] influence the process of conformational replication, and the delicate balance between states that allows these remarkable proteins to act as elements of inheritance.
